COVID-19 Impact on Global JAK and PI3K Signaling Pathway Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: C52968F47BE3EN
QYResearch

Abstracts

This report focuses on the global JAK and PI3K Signaling Pathway status, future forecast, growth opportunity, key market and key players. The study objectives are to present the JAK and PI3K Signaling Pathway development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Bayer HealthCare Pharmaceuticals
• AbbVie
• AstraZeneca
• Curis
• Daiichi Sankyo
• Exelixis
• Genentech
• Infinity Pharmaceuticals
• Merck & Co.
• Rigel Pharmaceuticals
• TG Therapeutics
• Sanofi Oncology
• Vertex Pharmaceuticals
• WILEX AG

Market segment by Type, the product can be split into

• PI3K
• Janus Kinase Therapies (Inhibitors)
• PI3K Therapies (Inhibitors)
• Signal Transduction Biomarkers for JAK and PI3K

Market segment by Application, split into

• Cancer
• Inflammatory Diseases
• Cardiac Ailments
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global JAK and PI3K Signaling Pathway status, future forecast, growth opportunity, key market and key players.
• To present the JAK and PI3K Signaling Pathway development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of JAK and PI3K Signaling Pathway are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by JAK and PI3K Signaling Pathway Revenue
1.4 Market Analysis by Type
  1.4.1 Global JAK and PI3K Signaling Pathway Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 PI3K
  1.4.3 Janus Kinase Therapies (Inhibitors)
  1.4.4 PI3K Therapies (Inhibitors)
  1.4.5 Signal Transduction Biomarkers for JAK and PI3K
1.5 Market by Application
  1.5.1 Global JAK and PI3K Signaling Pathway Market Share by Application: 2020 VS 2026
  1.5.2 Cancer
  1.5.3 Inflammatory Diseases
  1.5.4 Cardiac Ailments
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): JAK and PI3K Signaling Pathway Industry Impact
  1.6.1 How the Covid-19 is Affecting the JAK and PI3K Signaling Pathway Industry
    1.6.1.1 JAK and PI3K Signaling Pathway Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and JAK and PI3K Signaling Pathway Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for JAK and PI3K Signaling Pathway Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 JAK and PI3K Signaling Pathway Market Perspective (2015-2026)
2.2 JAK and PI3K Signaling Pathway Growth Trends by Regions
  2.2.1 JAK and PI3K Signaling Pathway Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 JAK and PI3K Signaling Pathway Historic Market Share by Regions (2015-2020)
  2.2.3 JAK and PI3K Signaling Pathway Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 JAK and PI3K Signaling Pathway Market Growth Strategy
  2.3.6 Primary Interviews with Key JAK and PI3K Signaling Pathway Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top JAK and PI3K Signaling Pathway Players by Market Size
  3.1.1 Global Top JAK and PI3K Signaling Pathway Players by Revenue (2015-2020)
  3.1.2 Global JAK and PI3K Signaling Pathway Revenue Market Share by Players (2015-2020)
  3.1.3 Global JAK and PI3K Signaling Pathway Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global JAK and PI3K Signaling Pathway Market Concentration Ratio
  3.2.1 Global JAK and PI3K Signaling Pathway Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by JAK and PI3K Signaling Pathway Revenue in 2019
3.3 JAK and PI3K Signaling Pathway Key Players Head office and Area Served
3.4 Key Players JAK and PI3K Signaling Pathway Product Solution and Service
3.5 Date of Enter into JAK and PI3K Signaling Pathway Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global JAK and PI3K Signaling Pathway Historic Market Size by Type (2015-2020)
4.2 Global JAK and PI3K Signaling Pathway Forecasted Market Size by Type (2021-2026)

5 JAK AND PI3K SIGNALING PATHWAY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global JAK and PI3K Signaling Pathway Market Size by Application (2015-2020)
5.2 Global JAK and PI3K Signaling Pathway Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America JAK and PI3K Signaling Pathway Market Size (2015-2020)
6.2 JAK and PI3K Signaling Pathway Key Players in North America (2019-2020)
6.3 North America JAK and PI3K Signaling Pathway Market Size by Type (2015-2020)
6.4 North America JAK and PI3K Signaling Pathway Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe JAK and PI3K Signaling Pathway Market Size (2015-2020)
7.2 JAK and PI3K Signaling Pathway Key Players in Europe (2019-2020)
7.3 Europe JAK and PI3K Signaling Pathway Market Size by Type (2015-2020)
7.4 Europe JAK and PI3K Signaling Pathway Market Size by Application (2015-2020)

8 CHINA

8.1 China JAK and PI3K Signaling Pathway Market Size (2015-2020)
8.2 JAK and PI3K Signaling Pathway Key Players in China (2019-2020)
8.3 China JAK and PI3K Signaling Pathway Market Size by Type (2015-2020)
8.4 China JAK and PI3K Signaling Pathway Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan JAK and PI3K Signaling Pathway Market Size (2015-2020)
9.2 JAK and PI3K Signaling Pathway Key Players in Japan (2019-2020)
9.3 Japan JAK and PI3K Signaling Pathway Market Size by Type (2015-2020)
9.4 Japan JAK and PI3K Signaling Pathway Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia JAK and PI3K Signaling Pathway Market Size (2015-2020)
10.2 JAK and PI3K Signaling Pathway Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia JAK and PI3K Signaling Pathway Market Size by Type (2015-2020)
10.4 Southeast Asia JAK and PI3K Signaling Pathway Market Size by Application (2015-2020)

11 INDIA

11.1 India JAK and PI3K Signaling Pathway Market Size (2015-2020)
11.2 JAK and PI3K Signaling Pathway Key Players in India (2019-2020)
11.3 India JAK and PI3K Signaling Pathway Market Size by Type (2015-2020)
11.4 India JAK and PI3K Signaling Pathway Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America JAK and PI3K Signaling Pathway Market Size (2015-2020)
12.2 JAK and PI3K Signaling Pathway Key Players in Central & South America (2019-2020)
12.3 Central & South America JAK and PI3K Signaling Pathway Market Size by Type (2015-2020)
12.4 Central & South America JAK and PI3K Signaling Pathway Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Bayer HealthCare Pharmaceuticals
  13.1.1 Bayer HealthCare Pharmaceuticals Company Details
  13.1.2 Bayer HealthCare Pharmaceuticals Business Overview and Its Total Revenue
  13.1.3 Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Introduction
  13.1.4 Bayer HealthCare Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2015-2020))
  13.1.5 Bayer HealthCare Pharmaceuticals Recent Development
13.2 AbbVie
  13.2.1 AbbVie Company Details
  13.2.2 AbbVie Business Overview and Its Total Revenue
  13.2.3 AbbVie JAK and PI3K Signaling Pathway Introduction
  13.2.4 AbbVie Revenue in JAK and PI3K Signaling Pathway Business (2015-2020)
  13.2.5 AbbVie Recent Development
13.3 AstraZeneca
  13.3.1 AstraZeneca Company Details
  13.3.2 AstraZeneca Business Overview and Its Total Revenue
  13.3.3 AstraZeneca JAK and PI3K Signaling Pathway Introduction
  13.3.4 AstraZeneca Revenue in JAK and PI3K Signaling Pathway Business (2015-2020)
  13.3.5 AstraZeneca Recent Development
13.4 Curis
  13.4.1 Curis Company Details
  13.4.2 Curis Business Overview and Its Total Revenue
  13.4.3 Curis JAK and PI3K Signaling Pathway Introduction
  13.4.4 Curis Revenue in JAK and PI3K Signaling Pathway Business (2015-2020)
  13.4.5 Curis Recent Development
13.5 Daiichi Sankyo
  13.5.1 Daiichi Sankyo Company Details
  13.5.2 Daiichi Sankyo Business Overview and Its Total Revenue
  13.5.3 Daiichi Sankyo JAK and PI3K Signaling Pathway Introduction
  13.5.4 Daiichi Sankyo Revenue in JAK and PI3K Signaling Pathway Business (2015-2020)
  13.5.5 Daiichi Sankyo Recent Development
13.6 Exelixis
  13.6.1 Exelixis Company Details
  13.6.2 Exelixis Business Overview and Its Total Revenue
  13.6.3 Exelixis JAK and PI3K Signaling Pathway Introduction
  13.6.4 Exelixis Revenue in JAK and PI3K Signaling Pathway Business (2015-2020)
  13.6.5 Exelixis Recent Development
13.7 Genentech
  13.7.1 Genentech Company Details
  13.7.2 Genentech Business Overview and Its Total Revenue
  13.7.3 Genentech JAK and PI3K Signaling Pathway Introduction
  13.7.4 Genentech Revenue in JAK and PI3K Signaling Pathway Business (2015-2020)
  13.7.5 Genentech Recent Development
13.8 Infinity Pharmaceuticals
  13.8.1 Infinity Pharmaceuticals Company Details
  13.8.2 Infinity Pharmaceuticals Business Overview and Its Total Revenue
  13.8.3 Infinity Pharmaceuticals JAK and PI3K Signaling Pathway Introduction
  13.8.4 Infinity Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2015-2020)
  13.8.5 Infinity Pharmaceuticals Recent Development
13.9 Merck & Co.
  13.9.1 Merck & Co. Company Details
  13.9.2 Merck & Co. Business Overview and Its Total Revenue
  13.9.3 Merck & Co. JAK and PI3K Signaling Pathway Introduction
  13.9.4 Merck & Co. Revenue in JAK and PI3K Signaling Pathway Business (2015-2020)
  13.9.5 Merck & Co. Recent Development
13.10 Rigel Pharmaceuticals
  13.10.1 Rigel Pharmaceuticals Company Details
  13.10.2 Rigel Pharmaceuticals Business Overview and Its Total Revenue
  13.10.3 Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Introduction
  13.10.4 Rigel Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2015-2020)
  13.10.5 Rigel Pharmaceuticals Recent Development
13.11 TG Therapeutics
  10.11.1 TG Therapeutics Company Details
  10.11.2 TG Therapeutics Business Overview and Its Total Revenue
  10.11.3 TG Therapeutics JAK and PI3K Signaling Pathway Introduction
  10.11.4 TG Therapeutics Revenue in JAK and PI3K Signaling Pathway Business (2015-2020)
  10.11.5 TG Therapeutics Recent Development
13.12 Sanofi Oncology
  10.12.1 Sanofi Oncology Company Details
  10.12.2 Sanofi Oncology Business Overview and Its Total Revenue
  10.12.3 Sanofi Oncology JAK and PI3K Signaling Pathway Introduction
  10.12.4 Sanofi Oncology Revenue in JAK and PI3K Signaling Pathway Business (2015-2020)
  10.12.5 Sanofi Oncology Recent Development
13.13 Vertex Pharmaceuticals
  10.13.1 Vertex Pharmaceuticals Company Details
  10.13.2 Vertex Pharmaceuticals Business Overview and Its Total Revenue
  10.13.3 Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Introduction
  10.13.4 Vertex Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2015-2020)
  10.13.5 Vertex Pharmaceuticals Recent Development
13.14 WILEX AG
  10.14.1 WILEX AG Company Details
  10.14.2 WILEX AG Business Overview and Its Total Revenue
  10.14.3 WILEX AG JAK and PI3K Signaling Pathway Introduction
  10.14.4 WILEX AG Revenue in JAK and PI3K Signaling Pathway Business (2015-2020)
  10.14.5 WILEX AG Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. JAK and PI3K Signaling Pathway Key Market Segments
Table 2. Key Players Covered: Ranking by JAK and PI3K Signaling Pathway Revenue
Table 3. Ranking of Global Top JAK and PI3K Signaling Pathway Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global JAK and PI3K Signaling Pathway Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of PI3K
Table 6. Key Players of Janus Kinase Therapies (Inhibitors)
Table 7. Key Players of PI3K Therapies (Inhibitors)
Table 8. Key Players of Signal Transduction Biomarkers for JAK and PI3K
Table 9. COVID-19 Impact Global Market: (Four JAK and PI3K Signaling Pathway Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for JAK and PI3K Signaling Pathway Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for JAK and PI3K Signaling Pathway Players to Combat Covid-19 Impact
Table 14. Global JAK and PI3K Signaling Pathway Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global JAK and PI3K Signaling Pathway Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global JAK and PI3K Signaling Pathway Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global JAK and PI3K Signaling Pathway Market Share by Regions (2015-2020)
Table 18. Global JAK and PI3K Signaling Pathway Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global JAK and PI3K Signaling Pathway Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. JAK and PI3K Signaling Pathway Market Growth Strategy
Table 24. Main Points Interviewed from Key JAK and PI3K Signaling Pathway Players
Table 25. Global JAK and PI3K Signaling Pathway Revenue by Players (2015-2020) (Million US$)
Table 26. Global JAK and PI3K Signaling Pathway Market Share by Players (2015-2020)
Table 27. Global Top JAK and PI3K Signaling Pathway Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in JAK and PI3K Signaling Pathway as of 2019)
Table 28. Global JAK and PI3K Signaling Pathway by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players JAK and PI3K Signaling Pathway Product Solution and Service
Table 31. Date of Enter into JAK and PI3K Signaling Pathway Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global JAK and PI3K Signaling Pathway Market Size by Type (2015-2020) (Million US$)
Table 34. Global JAK and PI3K Signaling Pathway Market Size Share by Type (2015-2020)
Table 35. Global JAK and PI3K Signaling Pathway Revenue Market Share by Type (2021-2026)
Table 36. Global JAK and PI3K Signaling Pathway Market Size Share by Application (2015-2020)
Table 37. Global JAK and PI3K Signaling Pathway Market Size by Application (2015-2020) (Million US$)
Table 38. Global JAK and PI3K Signaling Pathway Market Size Share by Application (2021-2026)
Table 39. North America Key Players JAK and PI3K Signaling Pathway Revenue (2019-2020) (Million US$)
Table 40. North America Key Players JAK and PI3K Signaling Pathway Market Share (2019-2020)
Table 41. North America JAK and PI3K Signaling Pathway Market Size by Type (2015-2020) (Million US$)
Table 42. North America JAK and PI3K Signaling Pathway Market Share by Type (2015-2020)
Table 43. North America JAK and PI3K Signaling Pathway Market Size by Application (2015-2020) (Million US$)
Table 44. North America JAK and PI3K Signaling Pathway Market Share by Application (2015-2020)
Table 45. Europe Key Players JAK and PI3K Signaling Pathway Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players JAK and PI3K Signaling Pathway Market Share (2019-2020)
Table 47. Europe JAK and PI3K Signaling Pathway Market Size by Type (2015-2020) (Million US$)
Table 48. Europe JAK and PI3K Signaling Pathway Market Share by Type (2015-2020)
Table 49. Europe JAK and PI3K Signaling Pathway Market Size by Application (2015-2020) (Million US$)
Table 50. Europe JAK and PI3K Signaling Pathway Market Share by Application (2015-2020)
Table 51. China Key Players JAK and PI3K Signaling Pathway Revenue (2019-2020) (Million US$)
Table 52. China Key Players JAK and PI3K Signaling Pathway Market Share (2019-2020)
Table 53. China JAK and PI3K Signaling Pathway Market Size by Type (2015-2020) (Million US$)
Table 54. China JAK and PI3K Signaling Pathway Market Share by Type (2015-2020)
Table 55. China JAK and PI3K Signaling Pathway Market Size by Application (2015-2020) (Million US$)
Table 56. China JAK and PI3K Signaling Pathway Market Share by Application (2015-2020)
Table 57. Japan Key Players JAK and PI3K Signaling Pathway Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players JAK and PI3K Signaling Pathway Market Share (2019-2020)
Table 59. Japan JAK and PI3K Signaling Pathway Market Size by Type (2015-2020) (Million US$)
Table 60. Japan JAK and PI3K Signaling Pathway Market Share by Type (2015-2020)
Table 61. Japan JAK and PI3K Signaling Pathway Market Size by Application (2015-2020) (Million US$)
Table 62. Japan JAK and PI3K Signaling Pathway Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players JAK and PI3K Signaling Pathway Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players JAK and PI3K Signaling Pathway Market Share (2019-2020)
Table 65. Southeast Asia JAK and PI3K Signaling Pathway Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia JAK and PI3K Signaling Pathway Market Share by Type (2015-2020)
Table 67. Southeast Asia JAK and PI3K Signaling Pathway Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia JAK and PI3K Signaling Pathway Market Share by Application (2015-2020)
Table 69. India Key Players JAK and PI3K Signaling Pathway Revenue (2019-2020) (Million US$)
Table 70. India Key Players JAK and PI3K Signaling Pathway Market Share (2019-2020)
Table 71. India JAK and PI3K Signaling Pathway Market Size by Type (2015-2020) (Million US$)
Table 72. India JAK and PI3K Signaling Pathway Market Share by Type (2015-2020)
Table 73. India JAK and PI3K Signaling Pathway Market Size by Application (2015-2020) (Million US$)
Table 74. India JAK and PI3K Signaling Pathway Market Share by Application (2015-2020)
Table 75. Central & South America Key Players JAK and PI3K Signaling Pathway Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players JAK and PI3K Signaling Pathway Market Share (2019-2020)
Table 77. Central & South America JAK and PI3K Signaling Pathway Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America JAK and PI3K Signaling Pathway Market Share by Type (2015-2020)
Table 79. Central & South America JAK and PI3K Signaling Pathway Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America JAK and PI3K Signaling Pathway Market Share by Application (2015-2020)
Table 81. Bayer HealthCare Pharmaceuticals Company Details
Table 82. Bayer HealthCare Pharmaceuticals Business Overview
Table 83. Bayer HealthCare Pharmaceuticals Product
Table 84. Bayer HealthCare Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2015-2020) (Million US$)
Table 85. Bayer HealthCare Pharmaceuticals Recent Development
Table 86. AbbVie Company Details
Table 87. AbbVie Business Overview
Table 88. AbbVie Product
Table 89. AbbVie Revenue in JAK and PI3K Signaling Pathway Business (2015-2020) (Million US$)
Table 90. AbbVie Recent Development
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Product
Table 94. AstraZeneca Revenue in JAK and PI3K Signaling Pathway Business (2015-2020) (Million US$)
Table 95. AstraZeneca Recent Development
Table 96. Curis Company Details
Table 97. Curis Business Overview
Table 98. Curis Product
Table 99. Curis Revenue in JAK and PI3K Signaling Pathway Business (2015-2020) (Million US$)
Table 100. Curis Recent Development
Table 101. Daiichi Sankyo Company Details
Table 102. Daiichi Sankyo Business Overview
Table 103. Daiichi Sankyo Product
Table 104. Daiichi Sankyo Revenue in JAK and PI3K Signaling Pathway Business (2015-2020) (Million US$)
Table 105. Daiichi Sankyo Recent Development
Table 106. Exelixis Company Details
Table 107. Exelixis Business Overview
Table 108. Exelixis Product
Table 109. Exelixis Revenue in JAK and PI3K Signaling Pathway Business (2015-2020) (Million US$)
Table 110. Exelixis Recent Development
Table 111. Genentech Company Details
Table 112. Genentech Business Overview
Table 113. Genentech Product
Table 114. Genentech Revenue in JAK and PI3K Signaling Pathway Business (2015-2020) (Million US$)
Table 115. Genentech Recent Development
Table 116. Infinity Pharmaceuticals Business Overview
Table 117. Infinity Pharmaceuticals Product
Table 118. Infinity Pharmaceuticals Company Details
Table 119. Infinity Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2015-2020) (Million US$)
Table 120. Infinity Pharmaceuticals Recent Development
Table 121. Merck & Co. Company Details
Table 122. Merck & Co. Business Overview
Table 123. Merck & Co. Product
Table 124. Merck & Co. Revenue in JAK and PI3K Signaling Pathway Business (2015-2020) (Million US$)
Table 125. Merck & Co. Recent Development
Table 126. Rigel Pharmaceuticals Company Details
Table 127. Rigel Pharmaceuticals Business Overview
Table 128. Rigel Pharmaceuticals Product
Table 129. Rigel Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2015-2020) (Million US$)
Table 130. Rigel Pharmaceuticals Recent Development
Table 131. TG Therapeutics Company Details
Table 132. TG Therapeutics Business Overview
Table 133. TG Therapeutics Product
Table 134. TG Therapeutics Revenue in JAK and PI3K Signaling Pathway Business (2015-2020) (Million US$)
Table 135. TG Therapeutics Recent Development
Table 136. Sanofi Oncology Company Details
Table 137. Sanofi Oncology Business Overview
Table 138. Sanofi Oncology Product
Table 139. Sanofi Oncology Revenue in JAK and PI3K Signaling Pathway Business (2015-2020) (Million US$)
Table 140. Sanofi Oncology Recent Development
Table 141. Vertex Pharmaceuticals Company Details
Table 142. Vertex Pharmaceuticals Business Overview
Table 143. Vertex Pharmaceuticals Product
Table 144. Vertex Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2015-2020) (Million US$)
Table 145. Vertex Pharmaceuticals Recent Development
Table 146. WILEX AG Company Details
Table 147. WILEX AG Business Overview
Table 148. WILEX AG Product
Table 149. WILEX AG Revenue in JAK and PI3K Signaling Pathway Business (2015-2020) (Million US$)
Table 150. WILEX AG Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global JAK and PI3K Signaling Pathway Market Share by Type: 2020 VS 2026
Figure 2. PI3K Features
Figure 3. Janus Kinase Therapies (Inhibitors) Features
Figure 4. PI3K Therapies (Inhibitors) Features
Figure 5. Signal Transduction Biomarkers for JAK and PI3K Features
Figure 6. Global JAK and PI3K Signaling Pathway Market Share by Application: 2020 VS 2026
Figure 7. Cancer Case Studies
Figure 8. Inflammatory Diseases Case Studies
Figure 9. Cardiac Ailments Case Studies
Figure 10. Others Case Studies
Figure 11. JAK and PI3K Signaling Pathway Report Years Considered
Figure 12. Global JAK and PI3K Signaling Pathway Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global JAK and PI3K Signaling Pathway Market Share by Regions: 2020 VS 2026
Figure 14. Global JAK and PI3K Signaling Pathway Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global JAK and PI3K Signaling Pathway Market Share by Players in 2019
Figure 17. Global Top JAK and PI3K Signaling Pathway Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in JAK and PI3K Signaling Pathway as of 2019
Figure 18. The Top 10 and 5 Players Market Share by JAK and PI3K Signaling Pathway Revenue in 2019
Figure 19. North America JAK and PI3K Signaling Pathway Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe JAK and PI3K Signaling Pathway Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China JAK and PI3K Signaling Pathway Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan JAK and PI3K Signaling Pathway Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia JAK and PI3K Signaling Pathway Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India JAK and PI3K Signaling Pathway Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America JAK and PI3K Signaling Pathway Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bayer HealthCare Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Bayer HealthCare Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2015-2020)
Figure 28. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. AbbVie Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2015-2020)
Figure 30. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. AstraZeneca Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2015-2020)
Figure 32. Curis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Curis Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2015-2020)
Figure 34. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Daiichi Sankyo Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2015-2020)
Figure 36. Exelixis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Exelixis Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2015-2020)
Figure 38. Genentech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Genentech Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2015-2020)
Figure 40. Infinity Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Infinity Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2015-2020)
Figure 42. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Merck & Co. Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2015-2020)
Figure 44. Rigel Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Rigel Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2015-2020)
Figure 46. TG Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. TG Therapeutics Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2015-2020)
Figure 48. Sanofi Oncology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Sanofi Oncology Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2015-2020)
Figure 50. Vertex Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Vertex Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2015-2020)
Figure 52. WILEX AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. WILEX AG Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed